20 May 2013
Keywords: fda, requests, new, versed, data, regulatory, authority
Article | 14 March 1994
The US regulatory authority has requested further data on the use of
intravenous and intramuscular forms of Roche's Versed (midazolam) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 March 1994
17 May 2013
© 2013 thepharmaletter.com